4Moncada S,Palmer R M,Higgs E A.Nitric oxide:physiology,pathophysiology and pharmacology[J].Pharmacol Rev,1991,43(2):109:142.
5Rezakovic D E,Goldner V,Batinic Z,et al.Intravenous isosorbide-5-mononitrate in the treatment of acute myocardial infarction[J].Am J Cardiol,1990,65:J50-J56.
6Drossman DA.Diagnosing and treating patients with refractory functional gast rointestinal disorders[J].Ann Intern Med, 1995,123 ( 9 ) : 688-697.
7Drossman DA.The functional gastrointestinal disorders and the rome process[J]. Gastroenterology,2006,130 ( 5 ) : 1377-1390.
8Drossman DA, Richter JE, Talley N J, et al.The functional gastrointestinal disorders: diagnosis, pathophysiolgy and treatment[M].Boston: Little Brown&Co, 1994: 1-74.
9Jackson JL, O' Malley PG, Tomkins G, et al.Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis[J]. Am J Med,2000,10g ( 1 ) : 65-72.
10Fishbain D.Evidence-based data on pain relief with antidepressants[J].Ann Med,2000,32 (5): 305-316.
